Seres Therapeutics Inc buy Quitte
Start price
17.08.16
/
50%
€10.03
Target price
17.02.17
€12.80
Performance (%)
-10.50%
End price
17.02.17
€8.97
Summary
This prediction ended on 17.02.17 with a price of €8.97. The price of Seres Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.50%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Seres Therapeutics Inc | -11.416% | -11.416% | -71.682% | -80.898% |
iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
Comments by Quitte for this prediction
In the thread Seres Therapeutics Inc diskutieren
hübsches Cash-Polster
und eine üble Abstrafung lassen mich hier zuversichtlich sein
(Laufzeit überschritten)